Insider Transactions Reported by 22 Insiders of NEUROCRINE BIOSCIENCES INC

Symbol
NBIX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

NEUROCRINE BIOSCIENCES INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
KEVIN CHARLES GORMAN Director $70,360,582 -$14,597,492 -17% 13 Feb 2026
Kyle Gano Chief Executive Officer, Director $19,504,108 -$4,873,049 -20% 12 Feb 2026
GARY A. LYONS Director $18,386,215 -$2,289,083 -11% 03 Dec 2025
Darin Lippoldt Chief Legal Officer $11,595,527 -$698,615 -5.7% 12 Feb 2026
ERIC BENEVICH Chief Commercial Officer $8,530,915 12 Feb 2026
MATT ABERNETHY Chief Financial Officer $6,744,854 04 Mar 2026
WILLIAM H. RASTETTER Director $6,127,297 -$6,038,642 -50% 05 Nov 2025
Malcolm Lloyd-Smith Chief Integration Officer $5,921,054 06 Feb 2023
EIRY ROBERTS Chief Medical Officer $5,231,201 12 Feb 2025
Julie Cooke Chief Human Resources Officer $4,724,704 12 Feb 2026
Jude Onyia Chief Scientific Officer $4,551,883 -$10,453,425 -70% 20 Feb 2026
RICHARD F. POPS Director $4,053,720 21 May 2025
Ingrid Delaet Chief Regulatory Officer $2,826,830 -$61,695 -2.1% 12 Feb 2026
David W. Boyer Chief Corp. Affairs Officer $2,297,658 12 Feb 2026
STEPHEN A. SHERWIN Director $1,715,243 02 Sep 2025
Leslie Norwalk V. Director $1,187,088 -$945,702 -44% 15 Dec 2025
MORROW GEORGE J Director $1,013,321 -$2,150,513 -68% 25 Nov 2025
Johanna Mercier Director $796,965 21 May 2025
Shalini Sharp Director $679,995 21 May 2025
Dimitri E. Grigoriadis Chief Research Officer $631,289 31 Jan 2022
Christine A. Poon Director $574,869 21 May 2025
Sanjay Chandru Keswani Chief Medical Officer 13 Feb 2026

Recent Insider Transactions by Companies or Individuals for NEUROCRINE BIOSCIENCES INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
MATT ABERNETHY NBIX Common Stock Gift -4.99% -2,249 42,808 04 Mar 2026 Direct
Jude Onyia NBIX Common Stock Gift -10.8% -3,110 25,670 20 Feb 2026 Direct
MATT ABERNETHY NBIX Common Stock Award 24.7% 9,968 50,259 13 Feb 2026 Direct
MATT ABERNETHY NBIX Common Stock Tax liability -16.9% -7,973 39,110 13 Feb 2026 Direct
MATT ABERNETHY NBIX Common Stock Options Exercise 13% 4,807 41,676 13 Feb 2026 Direct
MATT ABERNETHY NBIX Restricted Stock Unit Award 7,735 7,735 13 Feb 2026 Direct
MATT ABERNETHY NBIX Stock Option Award 44,095 44,095 13 Feb 2026 Direct
MATT ABERNETHY NBIX Restricted Stock Unit Options Exercise -65.2% -4,807 2,566 13 Feb 2026 Direct
David W. Boyer NBIX Common Stock Award 142.6% 9,968 16,959 13 Feb 2026 Direct
David W. Boyer NBIX Common Stock Tax liability -53.9% -7,188 6,158 13 Feb 2026 Direct
David W. Boyer NBIX Common Stock Options Exercise 72.6% 3,352 7,969 13 Feb 2026 Direct
David W. Boyer NBIX Restricted Stock Unit Award 5,479 5,479 13 Feb 2026 Direct
David W. Boyer NBIX Stock Option Award 31,234 31,234 13 Feb 2026 Direct
David W. Boyer NBIX Restricted Stock Unit Options Exercise -64.9% -3,352 1,812 13 Feb 2026 Direct
Kyle Gano NBIX Common Stock Award 6.82% 9,968 156,193 13 Feb 2026 Direct
Kyle Gano NBIX Common Stock Tax liability -5.21% -7,973 145,044 13 Feb 2026 Direct
Kyle Gano NBIX Common Stock Options Exercise 3.37% 4,807 147,610 13 Feb 2026 Direct
Kyle Gano NBIX Restricted Stock Unit Award 20,142 20,142 13 Feb 2026 Direct
Kyle Gano NBIX Stock Option Award 114,830 114,830 13 Feb 2026 Direct
Kyle Gano NBIX Restricted Stock Unit Options Exercise -65.2% -4,807 2,566 13 Feb 2026 Direct
Jude Onyia NBIX Common Stock Award 101.7% 19,935 39,535 13 Feb 2026 Direct
Jude Onyia NBIX Common Stock Tax liability -42.7% -13,673 18,349 13 Feb 2026 Direct
Jude Onyia NBIX Common Stock Options Exercise 34.5% 5,407 21,066 13 Feb 2026 Direct
Jude Onyia NBIX Restricted Stock Unit Award 9,669 9,669 13 Feb 2026 Direct
Jude Onyia NBIX Stock Option Award 55,119 55,119 13 Feb 2026 Direct
Jude Onyia NBIX Restricted Stock Unit Options Exercise -66.6% -5,407 2,717 13 Feb 2026 Direct
ERIC BENEVICH NBIX Common Stock Award 29.9% 16,613 72,153 13 Feb 2026 Direct
ERIC BENEVICH NBIX Common Stock Tax liability -17% -11,145 54,581 13 Feb 2026 Direct
ERIC BENEVICH NBIX Common Stock Options Exercise 7.69% 4,044 56,664 13 Feb 2026 Direct
ERIC BENEVICH NBIX Restricted Stock Unit Award 6,365 6,365 13 Feb 2026 Direct
ERIC BENEVICH NBIX Stock Option Award 36,287 36,287 13 Feb 2026 Direct
ERIC BENEVICH NBIX Restricted Stock Unit Options Exercise -66% -4,044 2,083 13 Feb 2026 Direct
Julie Cooke NBIX Common Stock Award 33.7% 9,968 39,548 13 Feb 2026 Direct
Julie Cooke NBIX Common Stock Tax liability -19.4% -6,949 28,885 13 Feb 2026 Direct
Julie Cooke NBIX Common Stock Options Exercise 10.6% 2,911 30,395 13 Feb 2026 Direct
Julie Cooke NBIX Restricted Stock Unit Award 4,754 4,754 13 Feb 2026 Direct
Julie Cooke NBIX Stock Option Award 27,100 27,100 13 Feb 2026 Direct
Julie Cooke NBIX Restricted Stock Unit Options Exercise -65.8% -2,911 1,510 13 Feb 2026 Direct
Darin Lippoldt NBIX Common Stock Gift -0.66% -365 54,729 13 Feb 2026 Direct
Darin Lippoldt NBIX Common Stock Award 19.7% 9,968 60,472 13 Feb 2026 Direct
Darin Lippoldt NBIX Common Stock Tax liability -13.3% -7,591 49,545 13 Feb 2026 Direct
Darin Lippoldt NBIX Common Stock Options Exercise 8.63% 4,100 51,628 13 Feb 2026 Direct
Darin Lippoldt NBIX Restricted Stock Unit Award 6,124 6,124 13 Feb 2026 Direct
Darin Lippoldt NBIX Stock Option Award 34,909 34,909 13 Feb 2026 Direct
Darin Lippoldt NBIX Restricted Stock Unit Options Exercise -66.3% -4,100 2,083 13 Feb 2026 Direct
Ingrid Delaet NBIX Common Stock Award 283% 19,935 26,980 13 Feb 2026 Direct
Ingrid Delaet NBIX Common Stock Tax liability -65.6% -12,245 6,420 13 Feb 2026 Direct
Ingrid Delaet NBIX Common Stock Options Exercise 55% 2,760 7,779 13 Feb 2026 Direct
Ingrid Delaet NBIX Restricted Stock Unit Award 5,479 5,479 13 Feb 2026 Direct
Ingrid Delaet NBIX Stock Option Award 31,234 31,234 13 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.